Chronic Rhinosinusitis With Nasal Polyps Crswnp clinical trials

Explore recruiting chronic rhinosinusitis with nasal polyps crswnp clinical trials.

Recruiting chronic rhinosinusitis with nasal polyps crswnp studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Rhinosinusitis With Nasal Polyps Crswnp trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Biomarkers for the prediction of individual CRSwNP patients' responses to mepolizumab

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/LY3650150 in Participants with Chronic Rhinosinusitis with Nasal Polyps on Background Intranasal Corticosteroids

Poland, Belgium, Spain, Germany, Denmark, Romania +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

English Title: Tapering of biologics in CRSwNP Subtitle: Tapering of Mepolizumab or Dupilumab after 12 months of complete or partial disease control in patients with severe chronic rhinosinusitis with nasal polyposis – a national Danish RCT.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Effect of Dupilumab on nasal epithelial barrier function in patients with Chronic Rhinosinusitis with nasal polyps (CRSwNP) – an exploratory pilot study

Austria

Therapeutic use (Phase IV) EU CTIS Study details

A single-arm extension study to investigate the long-term safety, tolerability, and efficacy of lunsekimig in adult participants with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) who completed a previous lunsekimig CRSwNP clinical study

Bulgaria, Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized Phase 2, double-blind, placebo-controlled, parallel-group, 2-arm study to assess the efficacy, safety, and tolerability of subcutaneous lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP)

Bulgaria, Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Rhinosinusitis With Nasal Polyps Crswnp trials by city

Chronic Rhinosinusitis With Nasal Polyps Crswnp clinical trials

Recruiting chronic rhinosinusitis with nasal polyps crswnp studies right now

Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery

Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy

Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP

A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma

Cognitive and Immunologic Profiles of Patients With Olfactory Dysfunction After Smell Training

Identifying Predictors Of Response To Mepolizumab In CRSwNP

A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab

Also recruiting in Europe

Biomarkers for the prediction of individual CRSwNP patients' responses to mepolizumab

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/LY3650150 in Participants with Chronic Rhinosinusitis with Nasal Polyps on Background Intranasal Corticosteroids

English Title: Tapering of biologics in CRSwNP Subtitle: Tapering of Mepolizumab or Dupilumab after 12 months of complete or partial disease control in patients with severe chronic rhinosinusitis with nasal polyposis – a national Danish RCT.

Effect of Dupilumab on nasal epithelial barrier function in patients with Chronic Rhinosinusitis with nasal polyps (CRSwNP) – an exploratory pilot study

A single-arm extension study to investigate the long-term safety, tolerability, and efficacy of lunsekimig in adult participants with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) who completed a previous lunsekimig CRSwNP clinical study

A randomized Phase 2, double-blind, placebo-controlled, parallel-group, 2-arm study to assess the efficacy, safety, and tolerability of subcutaneous lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP)

Chronic Rhinosinusitis With Nasal Polyps Crswnp trials by city

Other conditions